Sonova enters strategic alliance with French biotech company to treat hearing loss

In December last year, Sonova dished out almost EUR 5m to Sensorion, a French biotech company specialized in the treatment of hearing disorders. Now, the two companies are entering into a strategic partnership with the goal of improving diagnostics and treatment through genetic analysis.

Arnd Kaldowsk, CEO at Sonova | Photo: Sonova / PR/Daniel Hager Photography & Film

A French-Swiss alliance for hearing loss treatment has been formed.

In a press release, the French biotech company Sensorion announces that it has signed a deal with Swiss Sonova, the world's biggest manufacturer of hearing aids. Together, they want to develop new and improved hearing loss diagnoses, "thereby opening the way for improved care through a combination of advanced therapeutic interventions and traditional hearing aids," the statement reads.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs